Judge Hands Pfizer A Mixed Bag In Celebrex Case

Law360, New York (July 6, 2007, 12:00 AM EDT) -- Marking both good and bad news for Pfizer Inc., the judge overseeing the massive products liability litigation over anti-inflammatory pain medications Celebrex and Bextra has opted to let numerous claims stand against the pharmaceutical giant while tossing a slew of others.

On Thursday, U.S. District Judge Charles R. Breyer partially rejected Pfizer's request to bounce a bunch of claims sought by various third-party payor plaintiffs from the multidistrict, antitrust litigation currently playing out in the U.S. District Court for the Northern District of California.

“Defendants’ motion...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.